Search
for

    Sort by

    Research 181–210 of 1000+

    1. The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives Biology · 2026
    2. Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia International Journal of Nanomedicine · 2014 · 89 citations
    3. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis Nature Reviews Endocrinology · 2011 · 991 citations
    4. Polycystic ovary syndrome Nature Reviews Disease Primers · 2016 · 883 citations
    5. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology Best Practice & Research in Clinical Obstetrics & Gynaecology · 2004 · 131 citations
    6. Safety of testosterone treatment in postmenopausal women Fertility and Sterility · 2007 · 81 citations
    7. Testosterone therapy for sexual dysfunction in postmenopausal women Climacteric · 2008 · 46 citations
    8. Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats Journal of Pharmacy and Pharmacology · 2014 · 41 citations
    9. Combination of herbal extracts and platelet-rich plasma induced dermal papilla cell proliferation: involvement of ERK and Akt pathways Journal of Cosmetic Dermatology · 2013 · 39 citations
    10. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: A cross-sectional study Journal of The American Academy of Dermatology · 2013 · 38 citations
    11. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? Clinical Endocrinology · 2011 · 35 citations
    12. Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function Molecular Medicine · 2004 · 31 citations
    13. A study on the clinical and hormonal profile of patients with hirsutism Our Dermatology Online · 2012 · 4 citations
    14. To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application International Journal of Impotence Research · 2007 · 2 citations
    15. Hypoxia-Derived Mesenchymal Stem Cell Exosomes Downregulate CXCL12 and Upregulate IL-10 Expression in a Murine Model of Androgenic Alopecia Molecular and Cellular Biomedical Sciences · 2026
    16. A Systematic Review of the Potential Role of Cinnamomum spp. in Modulating Insulin Sensitivity and Hyperandrogenism in Polycystic Ovary Syndrome (PCOS) World Journal of Interdisciplinary Innovation Sciences · 2026
    17. A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies IP Indian Journal of Clinical and Experimental Dermatology · 2025
    18. Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence? 2023
    19. Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor Springer eBooks · 2016
    20. Drug Information Analysis Service Annals of Pharmacotherapy · 1994
    21. Novel inhibitors of 5α-reductase Expert Opinion on Therapeutic Patents · 2002 · 20 citations
    22. Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span The Journal of Clinical Endocrinology and Metabolism · 2005 · 414 citations
    23. Fully functional hair follicle regeneration through the rearrangement of stem cells and their niches Nature Communications · 2012 · 179 citations
    24. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update Clinical, Cosmetic and Investigational Dermatology · 2015 · 138 citations
    25. Estrogens and the skin Climacteric · 2005 · 137 citations
    26. Nutritional management in women with polycystic ovary syndrome: A review study Diabetes & Metabolic Syndrome: Clinical Research and Reviews · 2017 · 91 citations
    27. A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity The Journal of Clinical Endocrinology & Metabolism · 2005 · 91 citations
    28. Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss International Journal of Molecular Sciences · 2020 · 86 citations
    29. Dermatologic manifestations of endocrine disorders Translational pediatrics · 2017 · 86 citations
    30. Finasteride Drugs · 1993 · 86 citations